Orthocell Limited

ASX:OCC.AX

0.64 (AUD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q32013 Q2
Revenue 3.912.5573.3960.8470.7680.7640.5720.4460.3510.3680.4390.5070.3260.2930.2210.3090.2160.4510.4060.3840.290.4020.22900.295
Cost of Revenue 0.8220.7650.6710.5110.1770.5220.3790.3390.4690.2570.390.3420.240.230.1920.2460.1620.3360.3310.3220.2460.3510.24600.236
Gross Profit 3.0881.7932.7250.3360.590.2420.1920.107-0.1180.1110.0490.1650.0860.0640.0280.0630.0540.1150.0760.0620.0430.051-0.01700.059
Gross Profit Ratio 0.790.7010.8020.3960.7690.3170.3370.241-0.3350.3030.1110.3250.2620.2170.1290.2050.2490.2550.1860.1610.1490.127-0.07400.2
Reseach & Development Expenses 4.8353.8394.0213.5773.5073.3112.7174.6262.6032.8673.1122.4732.9051.732.361.5542.0461.3230.2980.4350.5050.1810.29400.157
General & Administrative Expenses 1.3552.2562.8711.3791.2141.0231.3441.911.1971.361.140.8791.0820.940.9050.880.7970.8050.4790.4150.3330.1650.31500.101
Selling & Marketing Expenses 1.4771.6080.9050.8052.5910.7070.8230.6420.530.9120.460.8241.0010.7850.4930.5710.470.5140.5720.3990.3130.2590.23100.294
SG&A 2.8323.8943.6862.1173.8741.6652.1272.51.7192.2641.61.7032.0831.7251.3981.4511.2671.3192.3482.771.6161.0491.15400.995
Other Expenses 0000000000000000000000000
Operating Expenses 7.6677.7347.7075.6957.3814.9764.8437.1264.3225.1324.54.1044.9073.273.3252.9283.032.4932.2782.8842.4270.3950.58300.807
Operating Income -4.579-5.941-4.981-5.359-6.791-4.734-4.651-7.019-4.44-5.02-4.577-3.94-4.826-3.206-3.3-2.865-2.976-2.378-2.202-2.822-2.384-0.344-0.60-0.748
Operating Income Ratio -1.171-2.323-1.467-6.328-8.846-6.195-8.134-15.73-12.633-13.638-10.43-7.772-14.812-10.928-14.945-9.27-13.8-5.275-5.422-7.342-8.228-0.857-2.6170-2.535
Total Other Income Expenses Net -0.4240.711-0.3731.3030.1940.080.0090.2290.3760.0280.1310.0050.0120.0110.0240.0150.0330.0290.0450.0780.010.0050.02500
Income Before Tax -5.002-5.23-5.354-4.057-6.597-4.654-4.642-6.79-4.064-4.992-4.446-3.934-4.814-3.195-3.276-2.85-2.943-2.35-2.157-2.744-2.373-0.339-0.5760-0.748
Income Before Tax Ratio -1.279-2.045-1.576-4.79-8.594-6.09-8.118-15.217-11.564-13.561-10.133-7.762-14.775-10.892-14.836-9.222-13.646-5.212-5.312-7.138-8.193-0.845-2.510-2.535
Income Tax Expense 3.0510-3.162-0-2.144-00-2.394-0-2.90502.52802.2521.94801.50801.15800.5300.53500.535
Net Income -1.951-5.23-2.192-4.057-4.453-4.654-4.642-4.395-4.064-2.087-4.446-1.406-4.814-0.943-1.328-2.85-1.435-2.35-0.999-2.744-1.843-0.339-1.1110-0.212
Net Income Ratio -0.499-2.045-0.645-4.79-5.801-6.09-8.118-9.85-11.564-5.67-10.133-2.774-14.775-3.215-6.013-9.222-6.655-5.212-2.46-7.138-6.362-0.845-4.8440-0.72
EPS -0.01-0.026-0.011-0.021-0.023-0.024-0.025-0.024-0.022-0.013-0.035-0.013-0.046-0.009-0.013-0.031-0.016-0.028-0.014-0.035-0.13-0.006-0.020-0.004
EPS Diluted -0.01-0.026-0.011-0.021-0.023-0.024-0.025-0.024-0.022-0.013-0.035-0.013-0.045-0.009-0.013-0.031-0.016-0.028-0.014-0.035-0.13-0.006-0.020-0.004
EBITDA -5.394-5.701-4.671-5.116-6.684-4.492-4.437-6.797-4.302-4.897-4.467-3.831-4.731-3.107-3.208-2.809-2.914-2.34-2.17-2.795-2.365-0.325-0.5840-0.719
EBITDA Ratio -1.379-2.229-1.375-6.041-8.707-5.879-7.76-15.233-12.242-13.304-10.18-7.558-14.522-10.591-14.53-9.089-13.513-5.19-5.343-7.272-8.164-0.809-2.5480-2.439